FIELD: organic chemistry, pharmacy. SUBSTANCE: invention describes compounds of semi-carbazone of the formula (I) where R1,R2,R3,R4 can be similar or different and mean halogen atom, C1-9-alkyl, cyano-group, C1-9-alkoxy-group or phenoxy-group; R5 means hydrogen atom or C1-9-alkyl; X means oxygen or sulfur atom under condition that: a) if X is sulfur atom then at least one of radicals R1 and R2 is not hydrogen atom but other substitute or at least one of radicals R3 and R4 is fluorine atom, C1-9-alkyl, cyano-group, C1-9-alkoxy-group; b) if X means oxygen atom, R5 means hydrogen atom, methyl or ethyl and one of radicals R1 and R2 is chlorine atom then other radical of R1 and R2 is not hydrogen or chlorine atom or at least one radical of R3 and R4 is not hydrogen atom but other substitute; c) if X means oxygen atom, R5 means hydrogen atom, methyl or ethyl and one of radicals R1 and R2 is methoxy-group then other radical of R1 and R2 is not hydrogen atom or methoxy-group or at least one radical of R3 and R4 is not hydrogen atom and other is a substitute; d) if X means oxygen atom, R5 means hydrogen atom, methyl or ethyl and one of radicals R1 and R2 is methyl then other radical of R1 and R2 is not hydrogen atom or at least one radical of R3 and R4 is not hydrogen atom but other substitute and e) if X means oxygen atom, R5 means hydrogen atom, methyl or ethyl and if both radicals R1 and R2 mean hydrogen atom then at least one radical of R3 and R4 is not hydrogen atom and methyl but other substitute, or their pharmaceutically acceptable salt. Compounds can be administrated orally for treatment of animals with convulsions. EFFECT: valuable pharmacological properties of compounds. 14 cl, 6 tbl, 3 dwg, 2 ex
Title |
Year |
Author |
Number |
2-PROPYL-2-PENTANIC OR 2-PROPYL-2-PENTENIC ACID AMIDE DERIVATIVES AND PHARMACEUTICAL COMPOSITION BASED THEREON |
1994 |
- Mejr Bialer
- Salim Khadad
- Jakob Kherzig
- Dzheff Sterling
- Dehvid Lerner
- Mitchell Shirvan
|
RU2140904C1 |
SUBSTITUTED TRIA-AZOLES AND METHODS RELATING THERETO |
2016 |
- Ashweek, Neil, J.
- Williams, John, P.
- Slee, Deborah
- Moorjani, Manisha
|
RU2718049C2 |
METHOD OF REALIZATION OF SELECTIVE METHIONINE CELL STARVATION IN MAMMAL BODY, POLYNUCLEOTIDE, CATALYTICALLY ACTIVE POLYPEPTIDE OF RECOMBINANT METHYLTHIOADENOSINE PHOSPHORYLASE |
1994 |
- Nobori Tsutomu
- Kason Dennis A.
|
RU2153885C2 |
METHOD FOR STRUCTURAL AND/OR FUNCTIONAL IMPROVEMENT OF ARTERIOLES |
2005 |
|
RU2414236C2 |
DERIVATIVES OF 4-PHENYLPYRROLIDONE WITH ANTICONVULSANT AND NOOTROPIC ACTIVITY AS MEANS OF TREATING EPILEPSY AND PAROXYSMAL CONDITIONS |
2017 |
- Voronina Tatyana Aleksandrovna
- Kovalev Ivan Georgievich
- Litvinova Svetlana Aleksandrovna
- Nerobkova Lyubov Nikolaevna
- Zhmurenko Lyudmila Aleksandrovna
- Mokrov Grigorij Vladimirovich
- Gudasheva Tatyana Aleksandrovna
- Durnev Andrej Dmitrievich
|
RU2748419C2 |
INDIVIDUAL FORMS OF ENANTIOMERS AND THEIR MIXTURES ALSO, PHARMACEUTICAL COMPOSITION CONTAINING THEREOF ELICITING ANTI-CONVULSANT EFFECT |
1997 |
- Choj Jong Mun
- Kim Min Vu
- Park Dzhong Khan
|
RU2171800C2 |
ELEUTEROBINS, METHOD FOR KILLING CELLS PRESENT IN CELL POPULATION |
1995 |
- Dzhensen Pol R.
- Lindel Tomas
- Finajkehl Uil'Jam Kh.
|
RU2146089C1 |
PEPTIDE POSSESSING ABILITY TO RELIEVE AT LEAST ONE SYMPTOM OF INFLAMMATORY CONDITION, PHARMACEUTICAL COMPOSITION CONTAINING IT AND METHOD OF TREATING ATHEROSCLEROSIS WITH THEIR APPLICATION |
2005 |
- Anantkharamajakh Gattadakhalli M.
- Navab Mokhamad
- Fogelmehn Ehlan M.
|
RU2448977C2 |
METHOD OF TREATMENT OF PSORIASIS |
1997 |
- Shehnk Richard P.
- Derian Klaudia K.
|
RU2207854C2 |
PSEUDOFRUCTOPYRANOSE SULFAMATES AND PHARMACEUTICAL COMPOSITION BASED ON SAID |
1994 |
- Majkl Dzh. Kostenzo
- Brjus E.Mar'Janov
- Dehvid F.Makkomsi
- Sehmjuel' D.Norti
|
RU2139875C1 |